These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 17130818)

  • 1. Deferoxamine-related fatal nasal-orbital-cerebral mucormycosis.
    Wu VC; Wang R; Lai TS; Wu KD
    Kidney Int; 2006 Dec; 70(11):1888. PubMed ID: 17130818
    [No Abstract]   [Full Text] [Related]  

  • 2. A massive intraventricular thrombosis by disseminated mucormycosis in a patient with myelodysplastic syndrome during deferoxamine therapy.
    Kubota N; Miyazawa K; Shoji N; Sumi M; Nakajima A; Kimura Y; Oshiro H; Ebihara Y; Ohyashiki K
    Haematologica; 2003 Nov; 88(11):EIM13. PubMed ID: 14607766
    [No Abstract]   [Full Text] [Related]  

  • 3. Intestinal mucormycosis in hemodialysis patients following deferoxamine.
    Eiser AR; Slifkin RF; Neff MS
    Am J Kidney Dis; 1987 Jul; 10(1):71-3. PubMed ID: 3605086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal mucormycosis therapy associated with deferoxamine.
    Slade MP; McNab AA
    Am J Ophthalmol; 1991 Nov; 112(5):594-5. PubMed ID: 1951600
    [No Abstract]   [Full Text] [Related]  

  • 5. Intestinal mucormycosis in a hemodialysis patient treated with desferrioxamine.
    Kaneko T; Abe F; Ito M; Hotchi M; Yamada K; Okada Y
    Acta Pathol Jpn; 1991 Jul; 41(7):561-6. PubMed ID: 1755321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disseminated mucormycosis in a hemodialyzed female patient treated with deferoxamine].
    Ponz E; Campistol JM; Ribalta T; Montoliú J; Ramírez J; Almirall J; Revert L
    Rev Clin Esp; 1991 Feb; 188(2):85-7. PubMed ID: 2041907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case report of rhinocerebral mucormycosis in hemodialysis patient receiving deferoxamine].
    Arizono K; Fukui H; Miura H; Hayano K; Otsuka Y; Tajiri M
    Nihon Jinzo Gakkai Shi; 1989 Jan; 31(1):99-103. PubMed ID: 2747004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal Aeromonas hydrophila bacteremia in a hemodialysis patient treated with deferoxamine.
    Lin SH; Shieh SD; Lin YF; De Brauwer E; Van Landuyt HW; Gordts B; Boelaert JR
    Am J Kidney Dis; 1996 May; 27(5):733-5. PubMed ID: 8629637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial mucormycosis with emboli in a hemodialysis patient.
    Scheer RL
    Am J Kidney Dis; 1987 Jul; 10(1):78. PubMed ID: 3605087
    [No Abstract]   [Full Text] [Related]  

  • 10. A massive intraventricular thrombosis by disseminated mucormycosis in a patient with myelodysplastic syndrome during deferoxamine therapy.
    Kubota N; Miyazawa K; Shoji N; Sumi M; Nakajima A; Kimura Y; Oshiro H; Ebihara Y; Ohyashiki K
    Haematologica; 2003 Sep; 88(9):EIM11. PubMed ID: 12969824
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute kidney injury due to deferoxamine in a renal transplant patient.
    Clajus C; Becker JU; Stichtenoth DO; Wortmann J; Schwarz A; Kielstein JT
    Nephrol Dial Transplant; 2008 Mar; 23(3):1061-4. PubMed ID: 18039640
    [No Abstract]   [Full Text] [Related]  

  • 12. [Development of arterial thrombus of Mucorales hyphae during deferoxamine therapy in a patient with aplastic anemia in transformation to myelodysplastic syndrome].
    Miyata Y; Kajiguchi T; Saito M; Takeyama H
    Rinsho Ketsueki; 2000 Feb; 41(2):129-34. PubMed ID: 10723242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retinopathy caused by desferrioxamine].
    Sánchez Dalmau BF; Vela Payán MD
    Med Clin (Barc); 1996 Nov; 107(16):636. PubMed ID: 9064398
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation and management of pediatric patients with anaphylactoid reactions to deferoxamine mesylate.
    Somech R; Seaban-Adel K; Atkinson A; Kirby-Allen M
    Ann Allergy Asthma Immunol; 2007 Dec; 99(6):575-6. PubMed ID: 18219844
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid development of severe toxic retinopathy associated with continuous intravenous deferoxamine infusion.
    Lai TY; Lee GK; Chan WM; Lam DS
    Br J Ophthalmol; 2006 Feb; 90(2):243-4. PubMed ID: 16424543
    [No Abstract]   [Full Text] [Related]  

  • 16. Deferoxamine for advanced hepatocellular carcinoma.
    Yamasaki T; Terai S; Sakaida I
    N Engl J Med; 2011 Aug; 365(6):576-8. PubMed ID: 21830988
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of desferoxamine on retinal and visual function.
    Lu M; Hansen RM; Cunningham MJ; Eklund SE; Fulton AB
    Arch Ophthalmol; 2007 Nov; 125(11):1581-2. PubMed ID: 17998528
    [No Abstract]   [Full Text] [Related]  

  • 18. Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry.
    Boelaert JR; Fenves AZ; Coburn JW
    Am J Kidney Dis; 1991 Dec; 18(6):660-7. PubMed ID: 1962650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal cardiac zygomycosis in a renal transplant patient treated with desferrioxamine.
    Hamdy NA; Andrew SM; Shortland JR; Boletis J; Raftery AT; Kanis JA; Brown CB
    Nephrol Dial Transplant; 1989; 4(10):911-3. PubMed ID: 2515497
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic and therapeutic challenges.
    Reddy S; Slakter J; Aaberg TM; Singh RP; Kaiser PK
    Retina; 2007 Jun; 27(5):642-7. PubMed ID: 17558329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.